CN108904720A - A kind of drug of therapeutic radiation portacaval mucositis - Google Patents
A kind of drug of therapeutic radiation portacaval mucositis Download PDFInfo
- Publication number
- CN108904720A CN108904720A CN201811037695.5A CN201811037695A CN108904720A CN 108904720 A CN108904720 A CN 108904720A CN 201811037695 A CN201811037695 A CN 201811037695A CN 108904720 A CN108904720 A CN 108904720A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- drug
- sunset abelmoschus
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of drugs of therapeutic radiation portacaval mucositis, drug is made of reed root, sunset abelmoschus flower, fungicide, peppermint extracting solution, radix paeoniae rubra, Radix Rehmanniae, Radix Ophiopogonis, honeysuckle, Prunella vulgaris, dendrobium nobile, Radix Glycyrrhizae, rhizoma nelumbinis, pure water, Radix Astragali, kuh-seng, Radix Isatidis, the coptis, cordate houttuynia, lily and vitamin, and the group of parts by weight is divided into：15~25 parts of reed root；6~15 parts of sunset abelmoschus flower.Drug of the invention is made of reed root, sunset abelmoschus flower, fungicide, peppermint extracting solution, radix paeoniae rubra, Radix Rehmanniae, Radix Ophiopogonis, honeysuckle, Prunella vulgaris, dendrobium nobile, Radix Glycyrrhizae, rhizoma nelumbinis, pure water, Radix Astragali, kuh-seng, Radix Isatidis, the coptis, cordate houttuynia, lily and vitamin, pure Chinese medicine formula, it is suitable for that various people use, fungicide can kill intraoral harmful bacteria simultaneously, to improve the therapeutic effect of this drug, and peppermint extracting solution can make faint scent of this drug with peppermint, keep entrance nice and cool, improves the comfort level of people's medication.
Description
Technical field
The present invention relates to technical field of pharmaceuticals, specially a kind of drug of therapeutic radiation portacaval mucositis.
Background technique
Portacaval mucositis is exactly canker sore, also known as " aphtha ", and the disease is most to be occurred between 20 years old to 50 years old, morbidity
When mostly with constipation, halitosis phenomena such as, which is when people are infected in restrovirus i.e. body, to ensconce caused by virus infection
Subepidermal blood vessel, and bred in nucleus, when body immune system exception, these viruses can especially active, the state of an illness
Can obviously it deteriorate, expert thinks, canker sore also belongs to a kind of " modern civilization diseases ", because being in over fatigue there are many patient
Fall ill afterwards, in addition, canker sore be recognized as it is related with factors such as heredity, hormone, such as canker sore meeting before feminine menstrual
There is deterioration situation, climacteric women case, which has, increases phenomenon, but then disease incidence is lower by period of pregnancy women, these phenomenons, which are all shown, bursts
The generation of ulcer is influenced by hormone variation, and the drug of existing treatment portacaval mucositis all contains western medicine composition, leads to pregnant woman et al.
Group should not take, and drug itself is more bitter, and children taking can generate very big resentment, for this purpose, it is proposed that a kind for the treatment of
The drug of radioactivity portacaval mucositis.
Summary of the invention
The purpose of the present invention is to provide a kind of drugs of therapeutic radiation portacaval mucositis, to solve above-mentioned background technique
The problem of middle proposition.
To achieve the above object, the present invention provides the following technical solutions：A kind of drug of therapeutic radiation portacaval mucositis,
Drug by reed root, sunset abelmoschus flower, fungicide, peppermint extracting solution, radix paeoniae rubra, Radix Rehmanniae, Radix Ophiopogonis, honeysuckle, Prunella vulgaris, dendrobium nobile, Radix Glycyrrhizae,
Rhizoma nelumbinis, pure water, Radix Astragali, kuh-seng, Radix Isatidis, the coptis, cordate houttuynia, lily and vitamin composition, the group of parts by weight are divided into：
15~25 parts of reed root；6~15 parts of sunset abelmoschus flower；5~15 parts of fungicide；6~15 parts of peppermint extracting solution；10~20 parts of radix paeoniae rubra；It is raw
15~25 parts of ground；8~16 parts of Radix Ophiopogonis；15~30 parts of honeysuckle；8~16 parts of Prunella vulgaris；8~20 parts of dendrobium nobile；3~15 parts of Radix Glycyrrhizae；
10~20 parts of rhizoma nelumbinis；200~400 parts of pure water；3~10 parts of Radix Astragali；5~8 parts of kuh-seng；4~10 parts of Radix Isatidis；The coptis 4~8
Part；4~10 parts of cordate houttuynia；2~6 parts of lily；5~10 parts of vitamin.
Preferably, the sunset abelmoschus flower is by sunset abelmoschus flower seed meal, sunset abelmoschus flower pollen, maniod ebish flower extract and yellow another name for Sichuan Province
Sunflower root powder composition, the group of parts by weight are divided into：12~18 parts of sunset abelmoschus flower seed meal；22~28 parts of sunset abelmoschus flower pollen；
45~50 parts of maniod ebish flower extract；10~15 parts of sunset abelmoschus flower root powder.
Preferably, the fungicide is selected from the derivative of ethyl alcohol, isopropanol, methyl p-hydroxybenzoate and para hydroxybenzene first
Acetoacetic ester, butyl p-hydroxybenzoate, propylparaben derivative, hydrogen peroxide, urea peroxide derivative and
Other fungicide, and other fungicide are selected from Chlorhexidine, chlorhexidine gluconate, pyrisept, triclosan
Or one of sodium hypochlorite.
Preferably, the peppermint extracting solution is made of base oil, Peppermint essential oil, borneol essential oil and sweet orange oil, weight
The group of number is divided into：15~25 parts of base oil；35~45 parts of Peppermint essential oil；25~35 parts of borneol essential oil；Sweet orange oil 10~20
Part.
Preferably, the vitamin is in vitamin C, vitamin E, vitamin B1, vitamin B2 or vitamin K
A kind of or any two or more mixture.
Preferably, preparation method includes the following steps：
A, by reed root, sunset abelmoschus flower, radix paeoniae rubra, Radix Rehmanniae, Radix Ophiopogonis, honeysuckle, Prunella vulgaris, dendrobium nobile, Radix Glycyrrhizae, rhizoma nelumbinis, Radix Astragali, kuh-seng,
Radix Isatidis, the coptis, cordate houttuynia and lily are dried for use after cleaning out；
B, reed root, sunset abelmoschus flower, radix paeoniae rubra, Radix Rehmanniae, Radix Ophiopogonis, honeysuckle, Prunella vulgaris, dendrobium nobile, Radix Glycyrrhizae, lotus root are weighed by formula rate
Section, Radix Astragali, kuh-seng, Radix Isatidis, the coptis, cordate houttuynia and lily, and weighed raw material is put into trash extraction box after removal impurity
It is put into togerther in drying box and carries out drying and processing, and drying temperature is 60~80 DEG C, drying time is 1~1.5h；
C, the raw material after drying is subjected to pulverization process；
D, smashed mixture is screened by the sieve of 80 molybdenums, and underproof raw material is reapposed over pulverizer
Interior carry out separating twice, until its qualification；
E, qualified raw material will be crushed to be put into decoction pot, first impregnates 30~45min with pure water, then boiled, and boil
20~30min is heated with 50~70 DEG C of constant temperatures afterwards；
F, after the completion of continuous heating, the fungicide of formula rate, peppermint extracting solution and vitamin are added in decoction pot, and even
10~15min of continuous stirring, finally cooled and filtered at normal temperature；
G, homogeneous deployed medicament is input in ultrahigh-temperature instant sterilizer, and the temperature control of ultrahigh-temperature instant sterilizer
Between 130~150 DEG C, between 0.75~0.85MPa, the time controls between 2~4s Steam pressure control；
H, medicament is poured into flask for medicinal preparations in sterile environment after sterilizing and is sealed in time.
Compared with prior art, beneficial effects of the present invention are as follows：
Drug of the invention is withered by reed root, sunset abelmoschus flower, fungicide, peppermint extracting solution, radix paeoniae rubra, Radix Rehmanniae, Radix Ophiopogonis, honeysuckle, summer
Grass, dendrobium nobile, Radix Glycyrrhizae, rhizoma nelumbinis, pure water, Radix Astragali, kuh-seng, Radix Isatidis, the coptis, cordate houttuynia, lily and vitamin composition, pure Chinese medicine
Formula is suitable for that various people use, while fungicide can kill intraoral harmful bacteria, to improve controlling for this drug
Therapeutic effect, and peppermint extracting solution can make this drug have the faint scent of peppermint, keep entrance nice and cool, improve the comfort level of people's medication.
Detailed description of the invention
Fig. 1 is ingredient table schematic diagram of the present invention.
Specific embodiment
Following will be combined with the drawings in the embodiments of the present invention, and technical solution in the embodiment of the present invention carries out clear, complete
Site preparation description, it is clear that described embodiments are only a part of the embodiments of the present invention, instead of all the embodiments.It is based on
Embodiment in the present invention, it is obtained by those of ordinary skill in the art without making creative efforts every other
Embodiment shall fall within the protection scope of the present invention.
Referring to Fig. 1, a kind of drug of therapeutic radiation portacaval mucositis, drug by reed root, sunset abelmoschus flower, fungicide,
Peppermint extracting solution, radix paeoniae rubra, Radix Rehmanniae, Radix Ophiopogonis, honeysuckle, Prunella vulgaris, dendrobium nobile, Radix Glycyrrhizae, rhizoma nelumbinis, pure water, Radix Astragali, kuh-seng, plate are blue
Root, the coptis, cordate houttuynia, lily and vitamin composition, the group of parts by weight are divided into：15~25 parts of reed root；Sunset abelmoschus flower 6~15
Part；5~15 parts of fungicide；6~15 parts of peppermint extracting solution；10~20 parts of radix paeoniae rubra；15~25 parts of Radix Rehmanniae；8~16 parts of Radix Ophiopogonis；Gold and silver
Spend 15~30 parts；8~16 parts of Prunella vulgaris；8~20 parts of dendrobium nobile；3~15 parts of Radix Glycyrrhizae；10~20 parts of rhizoma nelumbinis；Pure water 200~400
Part；3~10 parts of Radix Astragali；5~8 parts of kuh-seng；4~10 parts of Radix Isatidis；4~8 parts of the coptis；4~10 parts of cordate houttuynia；2~6 parts of lily；
5~10 parts of vitamin, pure Chinese medicine formula is suitable for that various people use, while fungicide can carry out intraoral harmful bacteria
It kills, to improve the therapeutic effect of this drug, and peppermint extracting solution can make this drug have the faint scent of peppermint, keep entrance nice and cool,
Improve the comfort level of people's medication.
Sunset abelmoschus flower is by sunset abelmoschus flower seed meal, sunset abelmoschus flower pollen, maniod ebish flower extract and sunset abelmoschus flower root powder group
At the group of parts by weight is divided into：12~18 parts of sunset abelmoschus flower seed meal；22~28 parts of sunset abelmoschus flower pollen；Sunset abelmoschus flower mentions
Take 45~50 parts of object；10~15 parts of sunset abelmoschus flower root powder.
Fungicide is selected from the derivative of ethyl alcohol, isopropanol, methyl p-hydroxybenzoate and ethyl-para-hydroxybenzoate, to hydroxyl
The derivative of yl benzoic acid butyl ester, propylparaben, the derivative and other fungicide of hydrogen peroxide, urea peroxide,
And other fungicide are in Chlorhexidine, chlorhexidine gluconate, pyrisept, triclosan or sodium hypochlorite
One kind.
Peppermint extracting solution is made of base oil, Peppermint essential oil, borneol essential oil and sweet orange oil, the component of parts by weight
For：15~25 parts of base oil；35~45 parts of Peppermint essential oil；25~35 parts of borneol essential oil；10~20 parts of sweet orange oil.
Vitamin is selected from one of vitamin C, vitamin E, vitamin B1, vitamin B2 or vitamin K or arbitrarily
Two or more mixtures.
Preparation method includes the following steps：
A, by reed root, sunset abelmoschus flower, radix paeoniae rubra, Radix Rehmanniae, Radix Ophiopogonis, honeysuckle, Prunella vulgaris, dendrobium nobile, Radix Glycyrrhizae, rhizoma nelumbinis, Radix Astragali, kuh-seng,
Radix Isatidis, the coptis, cordate houttuynia and lily are dried for use after cleaning out；
B, reed root, sunset abelmoschus flower, radix paeoniae rubra, Radix Rehmanniae, Radix Ophiopogonis, honeysuckle, Prunella vulgaris, dendrobium nobile, Radix Glycyrrhizae, lotus root are weighed by formula rate
Section, Radix Astragali, kuh-seng, Radix Isatidis, the coptis, cordate houttuynia and lily, and weighed raw material is put into trash extraction box after removal impurity
It is put into togerther in drying box and carries out drying and processing, and drying temperature is 60~80 DEG C, drying time is 1~1.5h；
C, the raw material after drying is subjected to pulverization process；
D, smashed mixture is screened by the sieve of 80 molybdenums, and underproof raw material is reapposed over pulverizer
Interior carry out separating twice, until its qualification；
E, qualified raw material will be crushed to be put into decoction pot, first impregnates 30~45min with pure water, then boiled, and boil
20~30min is heated with 50~70 DEG C of constant temperatures afterwards；
F, after the completion of continuous heating, the fungicide of formula rate, peppermint extracting solution and vitamin are added in decoction pot, and even
10~15min of continuous stirring, finally cooled and filtered at normal temperature；
G, homogeneous deployed medicament is input in ultrahigh-temperature instant sterilizer, and the temperature control of ultrahigh-temperature instant sterilizer
Between 130~150 DEG C, between 0.75~0.85MPa, the time controls between 2~4s Steam pressure control；
H, medicament is poured into flask for medicinal preparations in sterile environment after sterilizing and is sealed in time.
In use, withered by reed root, sunset abelmoschus flower, fungicide, peppermint extracting solution, radix paeoniae rubra, Radix Rehmanniae, Radix Ophiopogonis, honeysuckle, summer
Grass, dendrobium nobile, Radix Glycyrrhizae, rhizoma nelumbinis, pure water, Radix Astragali, kuh-seng, Radix Isatidis, the coptis, cordate houttuynia, lily and vitamin composition, pure Chinese medicine
Formula is suitable for that various people use, while fungicide can kill intraoral harmful bacteria, to improve controlling for this drug
Therapeutic effect, and peppermint extracting solution can make this drug have the faint scent of peppermint, keep entrance nice and cool, improve the comfort level of people's medication.
It although an embodiment of the present invention has been shown and described, for the ordinary skill in the art, can be with
A variety of variations, modification, replacement can be carried out to these embodiments without departing from the principles and spirit of the present invention by understanding
And modification, the scope of the present invention is defined by the appended.
Claims (6)
1. a kind of drug of therapeutic radiation portacaval mucositis, it is characterised in that：Drug is by reed root, sunset abelmoschus flower, fungicide, thin
Lotus extracting solution, radix paeoniae rubra, Radix Rehmanniae, Radix Ophiopogonis, honeysuckle, Prunella vulgaris, dendrobium nobile, Radix Glycyrrhizae, rhizoma nelumbinis, pure water, Radix Astragali, kuh-seng, Radix Isatidis,
The coptis, cordate houttuynia, lily and vitamin composition, the group of parts by weight are divided into：15~25 parts of reed root；6~15 parts of sunset abelmoschus flower；
5~15 parts of fungicide；6~15 parts of peppermint extracting solution；10~20 parts of radix paeoniae rubra；15~25 parts of Radix Rehmanniae；8~16 parts of Radix Ophiopogonis；Honeysuckle
15~30 parts；8~16 parts of Prunella vulgaris；8~20 parts of dendrobium nobile；3~15 parts of Radix Glycyrrhizae；10~20 parts of rhizoma nelumbinis；200~400 parts of pure water；
3~10 parts of Radix Astragali；5~8 parts of kuh-seng；4~10 parts of Radix Isatidis；4~8 parts of the coptis；4~10 parts of cordate houttuynia；2~6 parts of lily；Dimension life
5~10 parts of element.
2. a kind of drug of therapeutic radiation portacaval mucositis according to claim 1, it is characterised in that：The sunset abelmoschus root
Flower is made of sunset abelmoschus flower seed meal, sunset abelmoschus flower pollen, maniod ebish flower extract and sunset abelmoschus flower root powder, parts by weight
Group is divided into：12~18 parts of sunset abelmoschus flower seed meal；22~28 parts of sunset abelmoschus flower pollen；45~50 parts of maniod ebish flower extract；It is yellow
10~15 parts of Althaea roseal root powder.
3. a kind of drug of therapeutic radiation portacaval mucositis according to claim 1, it is characterised in that：The fungicide
Derivative selected from ethyl alcohol, isopropanol, methyl p-hydroxybenzoate and ethyl-para-hydroxybenzoate, butyl p-hydroxybenzoate,
The derivative of propylparaben, the derivative and other fungicide of hydrogen peroxide, urea peroxide, and other fungicide select
From one of Chlorhexidine, chlorhexidine gluconate, pyrisept, triclosan or sodium hypochlorite.
4. a kind of drug of therapeutic radiation portacaval mucositis according to claim 1, it is characterised in that：The peppermint mentions
Liquid is taken to be made of base oil, Peppermint essential oil, borneol essential oil and sweet orange oil, the group of parts by weight is divided into：Base oil 15~25
Part；35~45 parts of Peppermint essential oil；25~35 parts of borneol essential oil；10~20 parts of sweet orange oil.
5. a kind of drug of therapeutic radiation portacaval mucositis according to claim 1, it is characterised in that：The vitamin
Selected from one of vitamin C, vitamin E, vitamin B1, vitamin B2 or vitamin K or any two or more mixing
Object.
6. a kind of drug of therapeutic radiation portacaval mucositis according to any one of claims 1 to 5, it is characterised in that：
Preparation method includes the following steps：
A, by reed root, sunset abelmoschus flower, radix paeoniae rubra, Radix Rehmanniae, Radix Ophiopogonis, honeysuckle, Prunella vulgaris, dendrobium nobile, Radix Glycyrrhizae, rhizoma nelumbinis, Radix Astragali, kuh-seng,
Radix Isatidis, the coptis, cordate houttuynia and lily are dried for use after cleaning out；
B, reed root, sunset abelmoschus flower, radix paeoniae rubra, Radix Rehmanniae, Radix Ophiopogonis, honeysuckle, Prunella vulgaris, dendrobium nobile, Radix Glycyrrhizae, lotus root are weighed by formula rate
Section, Radix Astragali, kuh-seng, Radix Isatidis, the coptis, cordate houttuynia and lily, and weighed raw material is put into trash extraction box after removal impurity
It is put into togerther in drying box and carries out drying and processing, and drying temperature is 60~80 DEG C, drying time is 1~1.5h；
C, the raw material after drying is subjected to pulverization process；
D, smashed mixture is screened by the sieve of 80 molybdenums, and underproof raw material is reapposed over pulverizer
Interior carry out separating twice, until its qualification；
E, qualified raw material will be crushed to be put into decoction pot, first impregnates 30~45min with pure water, then boiled, and boil
20~30min is heated with 50~70 DEG C of constant temperatures afterwards；
F, after the completion of continuous heating, the fungicide of formula rate, peppermint extracting solution and vitamin are added in decoction pot, and even
10~15min of continuous stirring, finally cooled and filtered at normal temperature；
G, homogeneous deployed medicament is input in ultrahigh-temperature instant sterilizer, and the temperature control of ultrahigh-temperature instant sterilizer
Between 130~150 DEG C, between 0.75~0.85MPa, the time controls between 2~4s Steam pressure control；
H, medicament is poured into flask for medicinal preparations in sterile environment after sterilizing and is sealed in time.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811037695.5A CN108904720A (en) | 2018-09-06 | 2018-09-06 | A kind of drug of therapeutic radiation portacaval mucositis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811037695.5A CN108904720A (en) | 2018-09-06 | 2018-09-06 | A kind of drug of therapeutic radiation portacaval mucositis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108904720A true CN108904720A (en) | 2018-11-30 |
Family
ID=64406948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811037695.5A Pending CN108904720A (en) | 2018-09-06 | 2018-09-06 | A kind of drug of therapeutic radiation portacaval mucositis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108904720A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110151713A (en) * | 2019-05-22 | 2019-08-23 | 苏州知时生物科技有限公司 | Plant oral mucosa fibrosis chewable tablets and preparation method thereof |
| CN113559234A (en) * | 2021-09-01 | 2021-10-29 | 四川省医学科学院·四川省人民医院 | Traditional Chinese medicine for preventing and treating mucositis and using method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103405663A (en) * | 2013-07-10 | 2013-11-27 | 李俊萍 | Chinese medicine composition for aiding radiotherapy |
| CN103751579A (en) * | 2013-12-26 | 2014-04-30 | 柳州市中医院 | Pharmaceutical composition for treating oral mucositis caused by radiotherapy for nasopharyngeal carcinoma and preparation method of pharmaceutical composition |
| CN104906356A (en) * | 2015-03-23 | 2015-09-16 | 周世梅 | Mucous membrane care solution |
-
2018
- 2018-09-06 CN CN201811037695.5A patent/CN108904720A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103405663A (en) * | 2013-07-10 | 2013-11-27 | 李俊萍 | Chinese medicine composition for aiding radiotherapy |
| CN103751579A (en) * | 2013-12-26 | 2014-04-30 | 柳州市中医院 | Pharmaceutical composition for treating oral mucositis caused by radiotherapy for nasopharyngeal carcinoma and preparation method of pharmaceutical composition |
| CN104906356A (en) * | 2015-03-23 | 2015-09-16 | 周世梅 | Mucous membrane care solution |
Non-Patent Citations (3)
| Title |
|---|
| 吴桐: "鼻咽癌放疗配合中药防治放射性口腔黏膜炎临床分析", 《中国医药科学》 * |
| 孙建红: "玉屏风散合泻黄散加味治疗化疗所致口腔黏膜炎50例", 《浙江中医药大学学报》 * |
| 许毅等: "血液肿瘤化疗后口腔黏膜炎的中药治疗体会", 《新中医》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110151713A (en) * | 2019-05-22 | 2019-08-23 | 苏州知时生物科技有限公司 | Plant oral mucosa fibrosis chewable tablets and preparation method thereof |
| CN113559234A (en) * | 2021-09-01 | 2021-10-29 | 四川省医学科学院·四川省人民医院 | Traditional Chinese medicine for preventing and treating mucositis and using method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102139030B (en) | Oral Chinese herbal preparation for treating gingivitis and preparation method thereof | |
| CN103990081A (en) | Traditional Chinese medicine composition and application thereof in preparation of medicine for treating infant jaundice | |
| CN105998972A (en) | Bacteriostatic gel | |
| CN104984297A (en) | Application of pharmaceutical composition in preparation of drugs for treating amenorrhea | |
| CN107411987A (en) | A kind of clear acne compound essential oil of face and preparation method thereof | |
| CN108904720A (en) | A kind of drug of therapeutic radiation portacaval mucositis | |
| CN105617151A (en) | Powder boiling type traditional Chinese medicine antibacterial and anti-inflammatory agent, preparation method and applications thereof | |
| CN106309577A (en) | Antibacterial ointment for treating rhinitis and preparation method thereof | |
| CN104055935A (en) | Traditional Chinese medicine composition for improving immunity in synergetic mode | |
| CN101433658A (en) | Composition for preventing and treating chicken pox | |
| CN104606628A (en) | Face-nourishing, beautifying and chloasma-removing traditional Chinese medicine composition | |
| CN115227795A (en) | Compound medicine for treating HPV persistent infection and preparation method and application thereof | |
| CN103845616A (en) | Pharmaceutical composition for eliminating inflammation and disinfecting | |
| CN1262296C (en) | Medicine composition, preparing method and use for preparing gynacecopathia medicine | |
| CN102961647A (en) | Traditional Chinese medicine for treating osteoporosis | |
| CN103341044B (en) | Itching-relieving compound preparation and preparation method thereof | |
| CN1176794A (en) | Medicine for treating masculine sterility | |
| CN105213887A (en) | One is used for the treatment of glaucomatous Chinese medicine composition | |
| CN103110722B (en) | Traditional Chinese medicine for treating chronic pelvic inflammatory disease and preparation method thereof | |
| CN103893621A (en) | Traditional Chinese medicament for treating senile vaginitis | |
| CN102048903B (en) | Medicament for preventing and controlling damage of male reproduction by electromagnetic radiation and preparation method thereof | |
| CN110522842A (en) | Conducive to the medicament preparation method of dipping prevention and treatment vermin | |
| CN107519434A (en) | Pu Ling basin inflammation recovering particles and its quality determining method | |
| CN102895471B (en) | Medicine for treatment of acne, folliculitis and pustular herpes and preparation method thereof | |
| CN106309636B (en) | Pharmaceutical composition for uterine bleeding |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181130 |
|
| RJ01 | Rejection of invention patent application after publication |